All about COVID-19 in brief

Naserghandi, Alvand; Allameh, Seyed Farshad; Saffarpour, Reyhaneh

doi:10.1016/j.nmni.2020.100678

Cited by 67 publications

(70 citation statements)

References 20 publications

(35 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…At the beginning of the pandemic, two-third or 27 out of 41 reported cases had previously visited the Huanan seafood wholesale market where live animals were sold close to seafood and meat products, suggesting that the virus was transmitted from animals to humans (Guan et al, 2020;Harapan et al, 2020;Naserghandi et al, 2020). The genome of SARS-CoV-2 is closely related to the genomes of the SARS-CoV that caused the SARS epidemic during 2003 and the SARS-related-CoVs (SARSr-CoVs) that was isolated from horseshoe bats.…”

Section: Covid-19 Transmissionmentioning

confidence: 99%

“…The most plausible transmission routes are respiratory droplets dispersed via talking, sneezing and coughing or direct contact with infected persons. Other suggested routes are fecal-oral transmission, contaminated fomite transmission and mother-fetal vertical transmission (Naserghandi et al, 2020;Wang et al, 2020).…”

Section: Covid-19 Transmissionmentioning

confidence: 99%

“…In December 2019, SARS-CoV-2 was initially detected in patients who suffered from unusual viral pneumonia in Wuhan, Hubei, China (Kaul, 2020;Naserghandi et al, 2020;Petrosillo et al, 2020). The virus was first named 2019 novel coronavirus (2019-nCoV) by the WHO and later, when it was found that 86.9% of the novel virus genome was similar to the SARS-CoV genome, the virus was renamed SARS-CoV-2 (Chang et al, 2020;The Lancet Infectious Diseases, 2020).…”

Section: Introductionmentioning

confidence: 99%

“…Generally, COVID-19 symptoms involve fever, sore throat, runny or stuffy nose, dry cough, headache, myalgia or fatigue, sputum production, dyspnea, chest pain or pressure, joint pain, chills, loss of taste or smell, and a rash on the skin or discoloration of toes or fingers. Abdominal pain, dizziness, diarrhea, nausea, and vomiting are less common symptoms (Kaul, 2020;Naserghandi et al, 2020;Petrosillo et al, 2020). Borges do Nascimento et al (2020) found that COVID-19-related symptoms among 59,254 patients in 61 studies were: fever (82%), cough (61%), muscle aches and/or fatigue (36%), dyspnea (26%), headache (12%), sore throat (10%), and gastrointestinal symptoms (9%).…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Food Safety During and After the Era of COVID-19 Pandemic

et al. 2020

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2). COVID-19 was declared a pandemic by the World Health Organization (WHO) on March 11, 2020 due to its rapid and extensive spread among many countries through its very contagious nature and its high mortality among the elderly and infirm. Recently, data on the survival of SARS-CoV-2 on contact surfaces has been reported, but there is none on the survival of COVID-19 on food surfaces and packages. The potential survival and transmission of SARS-CoV-2 on/via food and packages are discussed based on data available for other respiratory viruses such as SARS-CoV and MERS-CoV. However, studies are needed to explore its transmission via food and survival on food packaging materials. The implementation of food safety management systems such as Hazard Analysis and Critical Control Points (HACCP), and Good Manufacturing Practices (GMP) are important to reduce the risk of COVID-19 infection. Cleaning, sanitation, good hygienic practices, and active packaging are also needed from farm to fork.

show abstract

Section: Covid-19 Transmissionmentioning

confidence: 99%

Section: Covid-19 Transmissionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Food Safety During and After the Era of COVID-19 Pandemic

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Specialists sequenced the genome of new infection and made sense of 86.9% of the genome is equivalent to the SARS-CoV genome. Subsequently the name was changed to Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) [ 8 ]. COVID-19 is decently irresistible with a generally high death rate, yet the data accessible out in the open reports and distributed writing is quickly expanding.…”

Section: Introductionmentioning

confidence: 99%

Novel coronavirus disease 2019 (COVID-19) pandemic: Considerations for the biomedical waste sector in India

Ramteke

Sahu

2020

Case Studies in Chemical and Environmental Engineering

View full text Add to dashboard Cite

In late December 2019, the world woke to a truth of a pandemic of Coronavirus Disease (COVID-19), inspired by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which has a place with a gathering of beta-coronavirus. As of July 21 India is still fighting to survive against the SARS-CoV-2 as called coronavirus disease. The contaminations, first constrained in the Kerala state, have inevitably spread to every single other area. The possibility to cause dangerous respiratory disappointment and quick transmission puts COVID-19 in the rundown of the Public Health Emergency of International Concern (PHEIC). There is a flow overall break out of the novel coronavirus Covid-19, which started from Wuhan in China and has now spread to more than 212 countries including 14,753,034 cases, as of 12:20 AM on July 21, 2020. Governments are feeling the squeeze to prevent the outbreak from spiralling into a worldwide wellbeing crisis. At this stage, readiness, straightforwardness, and sharing of data are vital to hazard evaluations and starting explosion control exercises. Since the episode of serious intense respiratory disorder (SARS) 18 years back, an enormous number of SARS-related coronaviruses (SARSr-CoVs) have been found in their regular repository have, bats. During this epidemic condition, expulsion of biomedical waste created from crisis facilities treating COVID-19 patients in like manner demands unprecedented thought as they can be potential bearers of the disease SARS-CoV-2. This article discusses the potential consequences of the COVID-19 pandemic on biomedical waste administrations, concentrating on basic focuses where option working methodology or extra moderation measures might be fitting.

show abstract

Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review

et al. 2021

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is an important health problem that has a serious adverse impact on the global economy and healthcare systems. The virus is not only involved in the respiratory system, but also causes other systemic effects as well as several gastrointestinal and liver issues. Evidence has shown direct viral invasion into the gastrointestinal tissue and supporting vascular network, causing various manifestations such as diarrhea, nausea, gastrointestinal bleeding, and abnormal liver function tests. The degree of gastrointestinal injury, especially in terms of liver involvement, is correlated with disease severity. There is no specific treatment for gastrointestinal involvement, and the symptoms can be managed with supportive therapy. Moreover, increased liver decompensation and mortality can be found in COVID-19-infected patients with coexisting liver disease. As the virus can be identified in gastrointestinal contents, endoscopic procedures during the pandemic should be carefully selected and proper protection strategies should be encouraged to prevent viral transmission.

show abstract

All about COVID-19 in brief

Cited by 67 publications

References 20 publications

Food Safety During and After the Era of COVID-19 Pandemic

Food Safety During and After the Era of COVID-19 Pandemic

Novel coronavirus disease 2019 (COVID-19) pandemic: Considerations for the biomedical waste sector in India

Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review

Contact Info

Product

Resources

About